Yong Mun

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX–Bevacizumab or FOLFIRI–Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study

Johanna C. Bendell, Tanios Bekaii‐Saab, Allen Lee Cohn et al. · The Oncologist · 2012 · 99 citations · Full text

Medicine, Oncology, Pharmacology +12

Modeled Prognostic Subgroups for Survival and Treatment Outcomes in <i>BRAF</i> V600–Mutated Metastatic Melanoma

Axel Hauschild, James Larkin, Antoni Ribas et al. · JAMA Oncology · 2018 · 96 citations · Full text

Medicine, Biostatistics, Oncology +17

Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study

Charles S. Cleeland, Musa Mayer, Nancy A Dreyer et al. · The Breast · 2014 · 75 citations · Full text

Medicine, Oncology, Breast Oncology +15

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

Jacob D. Soumerai, Ai Ni, Mohamed Darif et al. · The Lancet Haematology · 2019 · 67 citations · Full text

Medicine, Immunology, Oncology +16

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

Carla Casulo, Melissa C. Larson, Julianne J. Lunde et al. · The Lancet Haematology · 2022 · 63 citations · Full text

Medicine, Clinical Sciences, Oncology +12